NJORD – gateway to the Nordic region

Welcome to NJORD Law Firm.

We are a law firm with a Nordic profile and a global mindset. Our lawyers advise on legal matters and work as problem solvers for clients, both nationally and internationally, from our six offices – in Aarhus, Copenhagen, Silkeborg, Riga, Tallinn and Vilnius.

We give you direct advice in the form of effective solutions. We offer advice in more than 30 areas of expertise, and we currently think, speak and cooperate in more than 25 languages among our 260 employees. This makes us one of the strongest international law firms in the Nordic region.

Find employee

Latest news

NJORD Estonia: Can an office worker become an athlete?

According to the Sport Act, an adult athlete who, based on the nature of his or her work, is free to decide on the organisation of his or her working time, and an employer can agree that the athlete is an employee with independent decision-making power, provided that working does not damage the health and safety of the athlete. Thus, the following conditions are a prerequisite for independent decision-making competence: the employee must be an athlete, an adult, the nature of the work is one that allows free choice of working hours, the work is not harmful to health and is safe.

How to close a limited company in Latvia

Any company’s owners (members, partners, participants, shareholders) can choose to liquidate their private company (also called “winding up” a company) within the procedure of the shareholders’ voluntary liquidation, or a company can be liquidated in a result of violations of regulatory enactments, when the controlling state institution initiates the procedure of compulsory liquidation. In both cases, the result of the liquidation procedure will be the closure of the company and its exclusion from the Latvian Commercial Register.

What is the status on medical cannabis industry in Denmark 2020?

Denmark’s four-year pilot programme for medicinal cannabis has reached its midway point, and the industry continues to thrive. The four-year pilot programme started on 1 January 2018, and it offers a safe entry-point for entities wishing to enter the European medical cannabis market. The Danish Act on a Medicinal Cannabis Pilot Programme together with the Development Scheme enables companies to obtain a license to cultivate cannabis, manufacture and import primary products manufacture intermediate products, and to sell and export bulk and primary products.

Get the latest legal news

We gladly share our knowledge with you. Subscribe to our newsletters.

Subscribe here